Calton & Associates’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.3K	Buy	+11,170	New	+$22.4K	﹤0.01%	437
2024 Q1	–	Sell	-21,060	Closed	-$67.6K	–	193
2023 Q4	$67.6K	Buy	+21,060	New	+$59.7K	0.03%	241
2023 Q3	–	Sell	-22,907	Closed	-$114K	–	110
2023 Q2	$114K	Sell	22,907 -854	-4%	-$4.62K	0.05%	203
2023 Q1	$117K	Buy	23,761 +7,447	+46%	+$47.8K	0.05%	226
2022 Q4	$103K	Buy	16,314 +4,846	+42%	+$44.9K	0.04%	272
2022 Q3	$123K	Sell	11,468 -5,884	-34%	-$80K	0.07%	200
2022 Q2	$197K	Sell	17,352 -977	-5%	-$8.67K	0.11%	220
2022 Q1	$166K	Buy	+18,329	New	+$191K	0.05%	333
2021 Q4	–	Sell	-9,546	Closed	-$245K	–	368
2021 Q3	$245K	Buy	+9,546	New	+$227K	0.05%	332
2021 Q2	–	Sell	-6,067	Closed	-$214K	–	408
2021 Q1	$214K	Buy	+6,067	New	+$205K	0.04%	361